UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 213

Sortiert nach

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1624-1636

2003

Volltextzugriff (PDF)

In vivo models of primary brain tumors: pitfalls and perspectives

Neuro-oncology (Charlottesville, Va.), 2012-08, Vol.14 (8), p.979-993

2012

Volltextzugriff (PDF)

The progenitor cell marker NG2 MPG promotes chemoresistance by activation of integrin-dependent PI3K Akt signaling

Oncogene, 2008-09, Vol.27 (39), p.5182-5194

2008

Volltextzugriff (PDF)

Synthesis of novel Thioridazine derivates: in-vitro cytotoxicity and anticancer effect on glioblastoma

Brain & spine, 2021, Vol.1, p.100540, Article 100540

2021

Volltextzugriff (PDF)

200: Potential therapeutic targets for the hypoxic niche in glioblastoma

European journal of cancer (1990), 2014-07, Vol.50, p.S45-S45

2014

Volltextzugriff (PDF)

15 Cancer stem cells: current controversies

European journal of cancer supplements, 2010, Vol.8 (5), p.5-5

Bjerkvig, R

2010

Volltextzugriff (PDF)

Inhibition of medulloblastoma cell invasion by Slit

Oncogene, 2006-08, Vol.25 (37), p.5103-5112

2006

Volltextzugriff (PDF)

272 INVITED Optimising Treatment in Gliomas – Translational

European journal of cancer (1990), 2011, Vol.47, p.S63-S64

2011

Volltextzugriff (PDF)

161 INVITED Stem Cells

European journal of cancer (1990), 2011, Vol.47, p.S39-S39

2011

Volltextzugriff (PDF)

P06.03.A IMMORTALIZED MACROPHAGES AS A TOOL TO STUDY PHAGOCYTOSIS AND POLARIZATION IN VITRO

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii45-ii45

2023

Volltextzugriff (PDF)

P01.19 A GENOME-WIDE RNAI SYNTHETIC LETHAL SCREEN FOR SENSITIZERS OF GLIOBLASTOMA MULTIFORME TO TEMOZOLOMIDE

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii31-ii31

2014

Volltextzugriff (PDF)

O10.03 PHYSIOLOGICAL AND BIOLOGICAL RESPONSES OF HUMAN GLIOBLASTOMAS TO BEVACIZUMAB TREATMENT ASSESSED BY METABOLOMIC FLUX ANALYSIS

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii23-ii23

2014

Volltextzugriff (PDF)

O4.09 IN SITU METABOLIC PROFILING SHEDS LIGHT ON OXIDATIVE STRESS PATHWAYS IN IDH1 MUTANT OLIGODENDROGLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii9-ii9

2014

Volltextzugriff (PDF)

Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats

Journal of neuro-oncology, 2007-11, Vol.85 (2), p.191-202

2007

Volltextzugriff (PDF)

A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients

Neuropathology and applied neurobiology, 2011-02, Vol.37 (2), p.189-205

2011

Volltextzugriff (PDF)

P16.24 MULTIMODAL IMAGING ELUCIDATES PHYSIOLOGICAL AND METABOLIC CHANGES INDUCED BY ANTI-ANGIOGENIC THERAPY IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii83-ii83

2014

Volltextzugriff (PDF)

249 Side Population in Human Glioblastoma Does Not Characterize Cancer Stem Cell Populations and is Exclusively Stroma-derived

European journal of cancer (1990), 2012-07, Vol.48, p.S61-S61

2012

Volltextzugriff (PDF)

P17.30 ONCOGENIC EGFRVIII DRIVES PROTOTYPICAL SFK C-SRC ACTIVATION TO PROMOTE GLIOBLASTOMA ANGIOGENESIS

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii93-ii94

2014

Volltextzugriff (PDF)

OS06.6A Inhibition of GBM invasion by the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor antagonist Perampanel

Neuro-oncology (Charlottesville, Va.), 2021-09, Vol.23 (Supplement_2), p.ii10-ii10

2021

Volltextzugriff (PDF)

Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment

Gene therapy, 2010-02, Vol.17 (2), p.202-216

2010

Volltextzugriff (PDF)

P06.02.B GSDME-MEDIATED PYROPTOSIS IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii44-ii45

2023

Volltextzugriff (PDF)

Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype

Neuropathology and applied neurobiology, 2009-08, Vol.35 (4), p.380-393

2009

Volltextzugriff (PDF)

PO-197 Patient-derived xenograft (PDX) models of glioblastoma: from basic research to preclinical studies

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A303-A304

2018

Volltextzugriff (PDF)

SPOT-006 Stem cell-associated heterogeneity in glioblastoma is a result of intrinsic tumour plasticity shaped by the microenvironment

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A18-A18

2018

Volltextzugriff (PDF)

2308P CyPep-1 reprograms the tumor microenvironment and enhances the efficacy of immune checkpoint inhibitors

Annals of oncology, 2023-10, Vol.34, p.S1180-S1180

2023

Volltextzugriff (PDF)

1 – 25 von 213

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(180)

Publikationsform

Artikel
(211)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

In vivo models of primary brain tumors: pitfalls and perspectives

The progenitor cell marker NG2 MPG promotes chemoresistance by activation of integrin-dependent PI3K Akt signaling

Synthesis of novel Thioridazine derivates: in-vitro cytotoxicity and anticancer effect on glioblastoma

200: Potential therapeutic targets for the hypoxic niche in glioblastoma

15 Cancer stem cells: current controversies

Inhibition of medulloblastoma cell invasion by Slit

272 INVITED Optimising Treatment in Gliomas – Translational

161 INVITED Stem Cells

P06.03.A IMMORTALIZED MACROPHAGES AS A TOOL TO STUDY PHAGOCYTOSIS AND POLARIZATION IN VITRO

P01.19 A GENOME-WIDE RNAI SYNTHETIC LETHAL SCREEN FOR SENSITIZERS OF GLIOBLASTOMA MULTIFORME TO TEMOZOLOMIDE

O10.03 PHYSIOLOGICAL AND BIOLOGICAL RESPONSES OF HUMAN GLIOBLASTOMAS TO BEVACIZUMAB TREATMENT ASSESSED BY METABOLOMIC FLUX ANALYSIS

O4.09 IN SITU METABOLIC PROFILING SHEDS LIGHT ON OXIDATIVE STRESS PATHWAYS IN IDH1 MUTANT OLIGODENDROGLIOMA

Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats

A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients

P16.24 MULTIMODAL IMAGING ELUCIDATES PHYSIOLOGICAL AND METABOLIC CHANGES INDUCED BY ANTI-ANGIOGENIC THERAPY IN GLIOBLASTOMA

249 Side Population in Human Glioblastoma Does Not Characterize Cancer Stem Cell Populations and is Exclusively Stroma-derived

P17.30 ONCOGENIC EGFRVIII DRIVES PROTOTYPICAL SFK C-SRC ACTIVATION TO PROMOTE GLIOBLASTOMA ANGIOGENESIS

OS06.6A Inhibition of GBM invasion by the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor antagonist Perampanel

Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment

P06.02.B GSDME-MEDIATED PYROPTOSIS IN GLIOBLASTOMA

Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype

PO-197 Patient-derived xenograft (PDX) models of glioblastoma: from basic research to preclinical studies

SPOT-006 Stem cell-associated heterogeneity in glioblastoma is a result of intrinsic tumour plasticity shaped by the microenvironment

2308P CyPep-1 reprograms the tumor microenvironment and enhances the efficacy of immune checkpoint inhibitors

Suchergebnisse filtern